Notification of Major Interest in Shares

RNS Number : 6657I

Retroscreen Virology Group PLC

05 July 2013

 



For filings with the FCA include the annex
For filings with issuer exclude the annex
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESⁱ

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii				Retroscreen Virology
2 Reason for the notification (please tick the appropriate box or boxes):
An acquisition or disposal of voting rights					Yes
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments
An event changing the breakdown of voting rights
Other (please specify):
3. Full name of person(s) subject to the notification obligation: iii		Ruffer LLP (for its discretionary clients)
4. Full name of shareholder(s)  (if different from 3.):iv
5. Date of the transaction and date on which the threshold is crossed or reached: v		3 July 2013
6. Date on which issuer notified:		4 July 2013
7. Threshold(s) that is/are crossed or reached: vi, vii		Less than 5% to 5%

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

GB00B6ZM0X53

1,710,000

1,710,000

2,960,000

2,960,000

-

5.51%

-

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date xiii

Exercise/ Conversion Period xiv

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date xvii

Exercise/ Conversion period xviii

Number of voting rights instrument refers to

% of voting rights xix, xx

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

2,960,000

5.51%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi
N/A
Proxy Voting:
10. Name of the proxy holder:		N/A
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:	Ruffer LLP now controls the voting rights over 2,960,000 shares (5% of the voting rights) of Retroscreen Virology which are held by Ruffer LLP's discretionary clients. This change from less than 5% to 5% is due to Ruffer purchasing 1,250,000 shares in a recent placing of 12,750,000 shares. The new shares were admitted to the market on 3 July 2013.
14. Contact name:	Louise Stanway
15. Contact telephone number:	020 7963 8146

 

END

 

 

HOLRIMPTMBBMBRJ